Advanced Oncotherapy (AVO.L:LSE) Annual Reports & Investor Relations Material

Overview

Advanced Oncotherapy plc is a leading player in the healthcare industry, offering innovative solutions to treat cancer. With a focus on designing, assembling, and selling proton-based radiotherapy systems, the company's mission is to provide cutting-edge technology for cancer treatment. Its flagship product, Linac Image Guided Hadron Technology, is a proton therapy system that promises to revolutionize cancer treatment. In addition to its core business, the company also manages healthcare related properties. With operations spanning across the United Kingdom, Switzerland, and the United States, Advanced Oncotherapy plc is well-positioned to address the global challenge of cancer. Founded in 1994, the company is headquartered in London, the United Kingdom, and was formerly known as CareCapital Group plc before changing its name in September 2012.

Annual Reports

Frequently Asked Questions

What is Advanced Oncotherapy's ticker?

Advanced Oncotherapy's ticker is AVO.L

What exchange is Advanced Oncotherapy traded on?

The company's shares trade on the LSE stock exchange

Where are Advanced Oncotherapy's headquarters?

They are based in London, England

How many employees does Advanced Oncotherapy have?

There are 51-200 employees working at Advanced Oncotherapy

What is Advanced Oncotherapy's website?

It is https://www.avoplc.com/en-gb/

What type of sector is Advanced Oncotherapy?

Advanced Oncotherapy is in the Healthcare sector

What type of industry is Advanced Oncotherapy?

Advanced Oncotherapy is in the Medical Appliances & Equipment industry

Who are Advanced Oncotherapy's peers and competitors?

The following five companies are Advanced Oncotherapy's industry peers:

- Nemaura Medical

- Digirad Corporation

- Smith & Nephew

- Clearpoint Neuro

- Edwards Lifesciences